SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062428
Filing Date
2023-11-13
Accepted
2023-11-13 07:10:32
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-20230930.htm   iXBRL 10-Q 4002255
2 EX-31.1 ortx-ex31_1.htm EX-31.1 16885
3 EX-31.2 ortx-ex31_2.htm EX-31.2 16913
4 EX-32.1 ortx-ex32_1.htm EX-32.1 13587
  Complete submission text file 0000950170-23-062428.txt   13554055

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ortx-20230930_pre.xml EX-101.PRE 442785
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ortx-20230930_def.xml EX-101.DEF 253268
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ortx-20230930.xsd EX-101.SCH 78537
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ortx-20230930_lab.xml EX-101.LAB 568371
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ortx-20230930_cal.xml EX-101.CAL 70564
88 EXTRACTED XBRL INSTANCE DOCUMENT ortx-20230930_htm.xml XML 2692144
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 231395053
SIC: 2836 Biological Products, (No Diagnostic Substances)